DailyStocks Stock Article Search

https://www.zacks.com/stock/news/2321868/vyne-therapeutics-inc-vyne-reports-q2-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2321868 Aug 14, 2024 - VYNE Therapeutics (VYNE) delivered earnings and revenue surprises of -15.79% and 80%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock? 0

https://www.zacks.com/stock/news/2321665/silvercorp-svm-tops-q1-earnings-and-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2321665 Aug 13, 2024 - Silvercorp (SVM) delivered earnings and revenue surprises of 33.33% and 0.23%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock? 0

https://www.zacks.com/stock/news/2321666/westport-innovations-wprt-reports-q2-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2321666 Aug 13, 2024 - Westport (WPRT) delivered earnings and revenue surprises of 21.82% and 2.80%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock? 0

https://www.zacks.com/stock/news/2321645/xenetic-biosciences-xbio-reports-q2-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2321645 Aug 13, 2024 - Xenetic Biosciences (XBIO) delivered earnings and revenue surprises of 0% and 34.44%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock? 0

https://www.zacks.com/stock/news/2321644/biorestorative-therapies-inc-brtx-reports-q2-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2321644 Aug 13, 2024 - Biorestorative Therapies (BRTX) delivered earnings and revenue surprises of 10.71% and 196.67%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock? 0

https://www.zacks.com/stock/news/2321626/intrusion-inc-intz-reports-q2-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2321626 Aug 13, 2024 - Intrusion (INTZ) delivered earnings and revenue surprises of 26.39% and 16.80%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock? 0

https://www.zacks.com/stock/news/2321624/asensus-surgical-asxc-reports-q2-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2321624 Aug 13, 2024 - Asensus Surgical (ASXC) delivered earnings and revenue surprises of -40% and 69.77%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock? 0

https://www.zacks.com/stock/news/2321625/duos-technologies-group-inc-duot-reports-q2-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2321625 Aug 13, 2024 - Duos Technologies Group, Inc. (DUOT) delivered earnings and revenue surprises of -38.71% and 7.86%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock? 0

https://www.zacks.com/stock/news/2321620/zevra-therapeutics-zvra-reports-q2-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2321620 Aug 13, 2024 - Zevra Therapeutics (ZVRA) delivered earnings and revenue surprises of -2.13% and 8.96%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock? 0

https://www.zacks.com/stock/news/2321622/reeds-reed-reports-q2-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2321622 Aug 13, 2024 - Reeds (REED) delivered earnings and revenue surprises of -193.33% and 3.52%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock? 0